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The recognition of the prevalence of superficial mycotic infections has focused
attention on research and on the development of new anti-fungal agents; but
insufficient consideration has been given to the need for adequate methods of
determining the efficacy of these compounds and preparations. The lack of
suitable in vivo methods has made the laboratory investigator dependent upon
in vitro tests as a means of evaluating anti-fungal preparations employed in the
prophylaxis and treatment of superficial mycoses. These procedures are exten-
sively employed for this purpose despite the fact that they give a very inaccurate
picture of efficacy under conditions of use.
It has been known for some time that laboratory and domestic animals are
susceptible to infection by some of the dermatophytes 1—2). Recently a few
reports have appeared in the literature in which experimental mycotie infections
in laboratory animals were employed as a means of studying the in vivo activity
of anti-fungal ointments. Jadassohn and Pfanner (3) employed guinea pigs iii
their investigation of the in vivo activity of iodochloroxyquinoline, dichloroxy-
quinoline, and dichioroxyquinaldine in preventing Achorion quinckeanum infec-
tions. Nickerson and White (4) investigated the in vivo activity of ammoniated
silver nitrate ointment against a pathogenic dermatophyte on guinea pigs and
white rats. Reiss (5) studied the effect of sex hormones on experimental Tricho-
phyton rubrum (purpureum) infection induced in castrated rabbits. While the
investigation presented in this report was in progress, Frey (6) proposed the use
of an in vivo screening procedure which determined the ability of anti-mycotic
ointments to prevent or shorten the course of experimental Trichophyton men-
tagrophytes infections in guinea pigs.
The work here reported constitutes an endeavor to develop a controlled in vivo
laboratory method for screening anti-fungal ointments. In general, the screening
procedure employed compares the efficacy of anti-fungal ointments in preventing
typical T. mentagrophytes infection in guinea pigs with that of the ointment base
and with a medicated control on the same animals. Prolonged treatment with the
anti-fungal ointments is initiated as soon as possible after the cutaneous inocula-
tion of a predetermined number of spores. Four test areas are employed on the
same animal with a minimum of 4 test animals required to obtain statistically
significant results.
MATERIALS AND METHODS
Albino guinea pigs weighing 300—500 grns were prepared for inoculation
by clipping the hair from the sides and hack followed by treatment with a barium
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sulfide depilatory to remove the remaining stubble. A 24-hour period was a!-
lowed to elapse prior to inoculation of the test organism. All guinea pigs were
maintained in separate cages which were steam sterilized twice weekly through-
out the period of treatment and observation.
A pathogenic strain (A-280) of T. mentagrophytes* isolated from an adult
case of tinea barbae was employed as the test organism. Concentrated aqueous
spore suspensions were prepared from 6—8 day cultures grown on Sabouraud's
agar at 300 C., the number of spores determined by means of a hemocytometer,
and the suspensions diluted to contain the desired concentration of spores.
Four sites of inoculation were employed with each animal. These were located
in the center of each quarter of the guinea pig, namely, the left forequarter, left
rear quarter, right forequarter and right rear quarter. Two methods were em-
ployed for the cutaneous inoculation of the spores. Method A: each area ap-
proximately 1 cm in diameter was lightly excoriated by means of a motor-driven
stiff bristle brush for 10 seconds, and 0.5 ml of the desired spore suspension rubbed
into the area by means of sterile cotton swabs. Method B: 0.02 ml of the desired
suspension was applied to an area 1 cm in diameter and rubbed in by means of a
blunt instrument, the sterile handle of a scalpel, until a faint pink tinge appeared.
In an attempt to arrive at a thoroughly controlled procedure, four different
ointments were tested on the same animal, namely, the ointment base, a me di-
cated control—Compound Undecylenic Acid N. F. (8)—as suggested by Sulz-
berger's (7) method of paired comparison, and two investigational ointments
containing anti-mycotic agents under study. In order to reduce animal and area
variation to a minimum and to obtain statistically sigruficant results, the four
ointments were tested on a minimum of four guinea pigs and the areas of inoc-
ulation rotated so that each ointment was tested at least once in each of the 4
areas employed.
Treatment with the various ointments was initiated immediately after the
inoculation of the fourth area. The ointments were applied, rubbed in, and
spread as a thin layer over the inoculated area by means of tongue depressors.
Each area was cleansed with a damp cotton pledget and dried with sterile cotton
prior to each treatment. The therapeutic regimen was varied with the method
of inoculation as indicated in the Results.
All animals were kept under observation for at least 30 days. It was observed
that an obvious infection developed between the 6th and 14th day in the un-
treated animals. The following system of grading was devised, based on careful
observation of the clinical picture and the results of microscopic examination of
hairs and scrapings 12—14 days after initiation of treatment.
4+ A typical infection, consisting of erythema, crusting, and scaling which
spread beyond the area of trauma, and comparable in severity to that
obtained with the unmedicated ointment base on the same animal.
3+ An infection spreading beyond the area of inoculation but smaller in
size than that obtained with the control ointment base.
* Supplied by Dr. L. K. Georg, Mycology Laboratory, Communicable Disease Center,
U. S. Public Health Service, Chamblee, Georgia.
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2+ A typical infection confined to the original area of trauma.
1 + An area having minute infected papules or a normal appearing area
which is positive microscopically for the fungus in hairs and scrapings.
0 Complete absence of the infection.
Treatment with the ointment base alone did not alter the normal course of
infection which would progress through the typical phases of the incubation
period, climax, involution, and healing noted with T. mentagrophytes (3). By the
12—14th day, areas treated with the ointment base showed marked erythema,
scaling, crusting, and microscopic examination of scales and hairs treated with a
modified Hotchkiss-McManus (9) stain revealed the presence of spores and hy-
phal elements. By the 30th day, areas which had been infected were healed but
were marked by the presence of alopecia. The only difference noted between 2+,
3+, and 4 + lesions was in the size, otherwise all gave the appearance of a typical
infection.
Considerable contrast was observed between 1 + and 2+ infections. Areas
graded as 2+ gave the typical picture of erythema, scaling and crusting gener-
ally observed in this type of infection, whereas, 1+ infections were confined to
minute superficial papules within the area of trauma, or as was most often the
case, normal appearing areas from which the test organism could be observed in
hairs and scrapings on microscopic examination.
The anti-fungal compounds and the concentrations employed in this inves-
tigation are shown in Table I. They will, for the sake of conciseness, hereafter be
referred to only by the designated letter shown in the table. Polyethylene glycol
ointment TJ.S.P. (11) was employed as the ointment base for all the compounds
studied.
TABLE I
Designated Letter Compounds Studied*
"A" 2, 2'dihydroxy-5, 5'-dichlorodiphenylmethane 2%
"B" 2-dimethylamino-6- (beta-diethylamino ethoxy) benzathiazole
dihydrochioride 5%
"C" Benzoic Acid 12%
Salicylic Acid 6%
"D" Hexachiorophene (2, 2'dihydroxy-3,5,6,3', 5', 6', -hexachloro-
diphenylmethane) 1%
"E" 1 -methyl-piperidyl-4-benzhydryl ether 2%
"F" Sodium propionate 12%
Propionic Acid 3%
"G" Salicylanilide 5%
"H" Benzethonium chloride (diisobutylphenoxyethoxyethyldi-
methylbenzylammonium chloride) 1%
"I" Salicylanilide 5%
Benzethonium chloride 1%
"J" Undecylenic Acid 5%
(Med. Control) Zinc undecylenate 20%
* Incorporated in Polyethylene glycol ointment U.S.P.
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RESULTS
Preliminary investigation
A preliminary study with regard to the pathogenicity of the various strains of
T. mentagrophytes was conducted on 50 guinea pigs. It was found that strain
A-280, which was employed throughout this investigation, provided a relatively
long course of infection having an incubation period of 4—9 days, the lesions
reaching a climax in 14—20 days, and healing in 25—40 days. The size of the lesion
was to a degree dependent upon the level of inoculum. Infections obtained with
an inoculum of 500 spores/area were very superficial and occurred in isolated
spots within the area of trauma, whereas lesions produced by larger inocula,
5,000; 50,000; and 500,000 spores per area were solid and spread beyond the area
of inoculation.
In the determination of the medication schedule it was observed that applica-
tion of Compound Undecylenic Acid Ointment N.F. twice daily for periods of
1—6 consecutive days did not prevent experimental infections with an inoculum
of 50,000 spores. However, the lesions obtained in areas treated for 6 consecutive
days were comparable to those produced by an inoculum of 500 spores/area in
untreated areas. It was later found that application of this ointment twice daily
for a total of 8 days with 2 days of rest between the 4th and 5th day of treatment
resulted in limiting the lesions to small papules or complete prevention of the
infection. It was therefore adopted as the course of treatment for use with
Method A (areas excoriated with a brush).
Results with Method A
The results of screening various anti-fungal ointments with this procedure are
shown in Table II. It can be seen that the medicated control "J", though con-
sistently able to prevent the occurrence of a typical infection, was unable to
prevent the establishment of the fungus within the skin and hairs when tested
against a relatively large inoculum. This ointment was most effective when tested
against the smaller inoculum as it was able to prevent completely the infection
in 17 of the 27 trials conducted. Despite the use of a criterion of efficacy as the
prevention of a typical infection only two ointments "B" and "C", both con-
taining keratolytic agents, were found to be as effective as the medicated control.
Ointment "F", which contained a fatty acid and its sodium salt, showed con-
siderable activity, but did not appear to be as effective as the medicated control
or the keratolytic ointments tested. Most of the other ointments examined
were found to be only slightly more efficacious than the ointment base per se
though applied as soon as possible after the cutaneous inoculation of the test
organism.
Although Method A has the attribute of providing a means of testing oint-
ments in the presence of body fluids, it has the disadvantage of being harsh in
that the corneum is excoriated resulting iii the formation of a thin circular eschar
which may hinder the penetration of the ointment. It was also found that from
20 to 80 per cent of the spores were retained by the cotton swabs, making the
infective dose somewhat variable and uncertain. The disadvantages mentioned
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TABLE II
In vivo screening of enti-fungei ointments
Oiotmeot No. Pigs
Type of
Iofectioo
A
calYr Typical
1+) (2—4+)
Gfecuon Miceoscopie Examioatioo PrbtbilitY
looculum of 50,000 spores/area—Method A
"A"
"B"
"C"
"D"
"F"
"G"
"J"t
Oiot Base
8
6
5
5
10
9
27
27
0
6
5
0
6
3
27
0
8
0
0
5
4
6
0
27
3.5
0.5
0.6
3.4
2.3
2.1
0.3
4.0
4Pos
2Pos,4Neg
2Pos,3Neg
5Pos
lOPos
9Pos
10 Pos, 17 Neg
27Pos
<.0005
t
t
.004
t
.005
<.0005
Inoculum of 500,000 spores/area—Method A
"A"
"E"
"F"
"C"
"J"t
Oint Base
4
4
4
7
13
13
0
0
2
0
13
0
4
4
2
7
0
13
3.3
3.7
2.0
3.7
1.0
4.0
4Pos
4Pos
4Pos
7 Pos
13 Pos
l3Pos
.014
.014
t
.0003
<.0005
* Statistical analysis of the comparison of each ointment with the medicated control
"J" on the same group of animals was made by means of the Exact Treatment of Con-
tingency Tables as outlined by Fischer (12).
t Not statistically significant within the 5% level.
Medicated Control.
above led to an effort to determine whether the various anti-fungal ointments
might not be more effective against known numbers of spores applied super-
ficially to the unabraded skin as in Method B. The medication schedule was also
changed with Method B. All ointments were applied twice daily for 11 days,
except on the 1st, 5th, and 6th days when the areas were treated only once. The
ointments were rubbed into the skin with pressure for 1 mm. rather than 30
secs. employed in Method A.
Results with Method B
It was possible to screen a number of ointments utilizing a small inoculum
of 2,500 spores/area. Further use of this level of inoculum was discontinned as
consistent infection of areas treated with the control ointment base was not ob-
tained in succeeding trials. The results obtained in the single successful attempt
adds further significance to the results noted with an inoculum of 25,000 spores/
area, as shown in Table III. With the exception of ointment F*, none of the
ointments tested by Method B were as effective as the medicated control "J,"
* Keratolytic ointments "B" and "C" were not tested by Method B at the 25,000 spore
level.
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TABLE III
In vivo screening spores applied superficially
"A" 4
"B" 4
4
"F" 4
"C" 4
"J"t 12
Oint Base 12
0
4
1
4
0
12
0
4
0
3
0
4
0
12
3.0
0
2.5
0.5
3.0
0.5
4.0
4Pos
4Neg
3 Pos, 1 Neg
2Pos,2Neg
4 Pos
6 Pos, 6 Neg
12 Pos
.014
t
(.07)t
I
.014
<.0005
Inoculum of 25,000 spores/area—Method B
"A"
"D"
"F"
"C"
"H"
"I"
"J"t
Oint Base
10
10
11
12
11
12
33
33
0
1
9
0
1
1
33
0
10
9
2
12
10
11
0
33
3.6
3.6
0.8
3.3
3.5
3.2
0.5
4.0
lOPos
lOPos
7Pos,4Neg
l2Pos
11 Pos
l2Pos
14 Pos, 19 Neg
33Pos
<.0005
<.0005
t
<.0005
<.0005
<.0005
<.0005
* Statistical analysis of the comparison of each ointment with the medicated control
"J" on the same group of animals was made by means of the Exact Treatment of Contin-
gency Tables as outlined by Fischer (12).
I Not statistically significant within the 5% level.
I Medicated Control.
Though ointments "F" and "J" prevented the appearance of typical infection
they were unable to prevent consistently the establishment of the fungus within
the hairs and scales. It was possible to observe the presence of the test organism
on microscopic examination in 14 of 33 trials conducted with the medicated
control "J" and in 7 of 11 trials conducted with ointment "F."
Because of the poor results obtained with Salicylanilide "G", shown in Tables
II and III, and in view of the fact that this compound when incorporated into
ointments is generally employed in combination with a quaternary wetting agent,
the in vivo activity of this ointment was compared with ointments containing the
combination of salicylanilide plus a quarternary wetting agent "I" and with the
quaternary alone "H." The results obtained indicate that the presence of the
wetting agent did not enhance the activity of compound "G." All three ointments
appeared to be only slightly more effective than the ointment base per sc in
preventing the establishment of a typical experimental infection.
In a number of tests conducted with ointments containing fatty acids and their
salts it was noted that although the presence of the fungus was not detected by
Inoculum of 2,500 spores/area—Method B
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the 12—14th day, infected papules developed by the 20th day indicating that the
test organism had been inhibited, but not eradicated, by the use of these anti-
mycotic ointments. The trauma produced by the removal of hairs and scrapings
for microscopic examination appeared to set up the conditions for the superficial
infection. Further evidence in support of the view that the action of the medicated
control "J" is mainly fungistatic rather than fungicidal was noted in the following
experiments.
1) It was observed that the medicated control "J" was able to delay the
appearance of a typical infection in 6 animals when treatments twice daily for
7 consecutive days were initiated 4 days after the cutaneous inoculation of the
test organism. Typical symptoms of erythema, scaling, and crusting confined
to the area of inoculation appeared 3 days after cessation of treatment or 14 days
after inoculation of the test organism. Areas on the same animals which had been
treated with the ointment base were observed to be infected within 7 days after
inoculation.
2) This delayed type of infection was also observed in an experiment in which
9 guinea pigs, inoculated in a single area, were treated with the medicated control
"J" for 11 consecutive days and 9 control animals were treated with the ointment
base. Erythema typical of T. mentagrophytes infection appeared within 7 days
in all animals treated with the ointment base, whereas no outward sign of the
infection was noted within 14 days in animals treated with the medicated control.
Microscopic examination revealed the presence of the test organism in 5 of the 9
animals treated with ointment "J." By the 20th day, infected lesions on animals
treated with the ointment base were undergoing involution, whereas symptoms
of the infection were starting to appear in 7 of the 9 animals treated with the
medicated control "J." This would appear to indicate that the action of ointment
"J" had been that of inhibition and protection of the surrounding area, but not
eradication of those spores which had established themselves within the hairs and
follicles.
A review of the results obtained with Methods A and B, shown in Tables II
and III, reveals that ointments containing the combination of 12 % benzoic
acid—6 % salicylic acid, "C," the benzathiazole ether, "B," and the two fatty
acids and their salts, "F" and "J", were capable of preventing a typical T.
mentagrophytes infection within the 12—14 day period. Of the 4 agents mentioned
above, ointment "F" was the least efficient.
In Vitro Results
The fungistatic and fungicidal activity of the anti-mycotic preparations were
tested by the agar cup plate method (10) and by the wet filter paper method
utilizing the same concentrated spore suspension employed in the in vivo screening
procedures. The in vitro activity of the various preparations studied are shown in
Table IV.
A comparison of the results obtained in vivo with those obtained in vitro shows
that there was no correlation between the in vivo and in vitro activity. Ointments,
such as those containing compounds "A," "D," "G," "H," and "I", which were
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TABLE IV
In vitro activity of anti-fungal ointments
Ointment Agar Cup Plate Test(Zone of Inhibition)
Wet Filter Paper Test
1 hour 2 hours*
"A" 1.5 cm — —
"B" 2.0 cm + +
"C" 2.0 cm — —
"D" 0.8 cm — —
"E" 0.4 cm + +
"F" 0.8 cm + +
"G" 1.0 cm — —
"H" 1.0 cm — —
"I" 2.0 cm — —
''J''j 1.0 cm — —
Oint Base 0 + +
* Period in which test organism was in contact with ointment.
+ = growth.
— = no growth.
Medicated Control.
highly active in vitro were practically inactive in vivo. These results support the
views of Muskatblit (13), Sulzberger (7), et al, and Combes (14) whofeelthatthere
is no constant relationship between in vitro activity and efficacy under conditions
of use.
DISCUSSION
A procedure in which the superficial inoculation of a small number of spores is
followed by immediate and prolonged treatment with the anti-mycotic ointment,
and which employs as criterion of activity the prevention of a typical infection
rather than complete eradication of the test organism, would appear to be one
which presents more than ample opportunity for anti-mycotic agents to show
their activity.
The fact that many of the agents tested by this procedure were unable to
prevent the establishment of a typical infection would appear to indicate, at
least, when incorporated in a polyethylene glycol base, that they would have
little or no effect on T. mentagrophytes where this organism has a fertile field for
the establishment of the pathological condition.
Employment of laboratory animals in screening anti-fungal preparations
presents an opportunity for the research and regulatory worker to test various
anti-mycotic compounds and preparations under controlled conditions which
more closely simulate actual conditions of use than do the various in vitro meth-
ods now available. Laboratory screening procedure of this type should, of course,
be preliminary to undertaking the more difficult, time-consuming and expensive
controlled clinical studies which are the final step in the evaluation of anti-fungal
preparations.
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It is felt that in vivo screening procedures should also be developed utilizing
Epidermophyton floccosum, Trichophyton rubrum, and other dermatophytes which
have been reported to be pathogenic for animals as well as man.
SUMMARY
An in vivo procedure utilizing T. mentagrophytes as the test organism and
guinea pigs as the test subjects was employed as a means of screening the activity
of anti-fungal ointments under conditions which more closely approximate
actual usage than do the various in vitro tests now employed.
The capacity of a number of ointments to prevent the establishment of a
typical T. mentagrophytes infection within 12—14 days was compared with that
of a medicated control ointment and the ointment base. This comparison was
made on the same animal. The medicated control contained the combination of
undecylenic acid and its zinc salt as active ingredients.
Of the agents tested, two ointments containing keratolytic agents and one con-
taining a fatty acid and its sodium salt were found to compare favorably with the
medicated control.
No correlation between in vitro and in vivo activity was noted. A number of
ointments which were highly active in vitro were unable to prevent the establish-
ment of a typical T. mentagrophytes infection despite their immediate and pro-
longed application after the cutaneous inoculation of the test organism.
Thanks are extended to Dr. L. K. Georg, Mycology Laboratory, Communicable Disease
Center, U.S.P.H.S., Chamblee, Georgia, who supplied the pathogenic strains of T. mentagro-
phytes and helpful advice concerning cutaneous inoculation of susceptible animals. The
author also wishes to express his grateful appreciation to Dr. C. W. Emmons, Principal
Mycologist, Division of Infectious Diseases, National Institutes of Health, for helpful
advice and criticism and to William Weiss, Statistical Unit, Food and Drug Administration,
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